Randomized phase II clinical trials of Wellmune WGP® for immune support during cold and flu season

Journal of Applied Research

Volumn 9, Issue 1-2, 2009, Pages 30-42

  Feldman, Samantha ^c   Schwartz, Howard I ^a   Kalman, Douglas S ^a   Mayers, Athena ^a   Kohrman, Hannah M ^c   Clemens, Roger ^b   Krieger, Diane R ^a  

^a MIAMI RESEARCH ASSOCIATES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c USC School of Pharmacy ^*

Author keywords

Beta glucans; Common cold; Human influenza

Indexed keywords

BETA 1,3 GLUCAN; BETA 1,6 GLUCAN; BETA GLUCAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG SAFETY; FOLLOW UP; HUMAN; IMMUNE SYSTEM; INFLUENZA; PATIENT COMPLIANCE; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; SCORING SYSTEM;

EID: 68249142919     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Bramley TJ, Lerner D, Sames M. Productivity losses related to the common cold. J Occup Environ Med 2002;44(9):822-829
2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007;25(27):5086-5096 (Pubitemid 46879994)
3. Barrett BP, Brown RL, Locken K, Maberry R, Bobula JA, D'Alessio D. Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2002;137(12):939-946 (Pubitemid 35440239)
4. Goel V, Lovlin R, Barton R, Lyon MR, Bauer R, Lee TD, Basu TK. Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther 2004;29(1):75-83. (Pubitemid 38253541)
5. Henneicke-von Zepelin H, Hentschel C, Schnitker J, Kohnen R, Kohler G, Wustenberg P. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study. Curr Med Res Opin 1999;15(3):214-227 (Pubitemid 29481480)
6. Linde K, Barrett B, Wolkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2006;(1):CD000530. (Pubitemid 46841368)
7. Melchart D, Linde K, Fischer P, Kaesmayr J. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2000;(2):CD000530.
8. Naser B, Lund B, Henneicke-von Zepelin HH, Kohler G, Lehmacher W, Scaglione F. A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common cold. Phytomedicine 2005;12(10):715-722 (Pubitemid 41505327)
9. Schoop R, Klein P, Suter A, Johnston SL. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther 2006;28(2):174-183
10. Schulten B, Bulitta M, Ballering-Bruhl B, Koster U, Schafer M. Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial. Arzneimittelforschung 2001;51(7):563-568 (Pubitemid 32664394)
11. Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto AS. Echinacea purpurea for prevention of experimental rhinovirus colds. Clin Infect Dis 2004;38(10):1367-1371 (Pubitemid 38668580)
12. Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JD. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 2005;353(4):341-348 (Pubitemid 41132338)
13. Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2004;164(11):1237-1241 (Pubitemid 39030362)
14. Peters EM, Goetzsche JM, Grobbelaar B, Noakes TD. Vitamin C supplementation reduces the incidence of postrace symptoms of upper-respiratory-tract infection in ultra-marathon runners. Am J Clin Nutr 1993;57(2):170-174 (Pubitemid 23039887)
15. Elwood PC, Lee HP, St Leger AS, Baird M, Howard AN. A randomized controlled trial of vitamin C in the prevention and amelioration of the common cold. Br J Prev Soc Med 1976;30(3):193-196
16. Sasazuki S, Sasaki S, Tsubono Y, Okubo S, Hayashi M, Tsugane S. Effect of vitamin C on common cold: randomized controlled trial. Eur J Clin Nutr 2006;60(1):9-17. (Pubitemid 43731069)
17. Van SM, Josling P. Preventing the common cold with a vitamin C supplement: a double-blind, placebo-controlled survey. Adv Ther 2002;19(3):151-159 (Pubitemid 34894201)
18. Schmiedel V, Klein P. A complex homeopathic preparation for the symptomatic treatment of upper respiratory infections associated with the common cold:An observational study. Explore (NY) 2006;2(2):109-114 (Pubitemid 43380630)
19. Winkler P, de Vrese M, Laue Ch, Schrezenmeir J. Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. Int J Clin Pharmacol Ther 2005;43(7):318-326 (Pubitemid 40974738)
20. Predy GN, Goel V, Lovlin R, Donner A, Stitt L, Basu TK. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl- saccharides for preventing upper respiratory tract infections: a randomized controlled trial. CMAJ 2005;173(9):1043-1048 (Pubitemid 41546691)
21. Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, Hamer DH. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 2004;292(7):828-836
22. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 2002;288(6):715-721
23. Belongia EA, Berg R, Liu K. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults. Am J Med 2001;111(2):103-108 (Pubitemid 32728401)
24. Eby GA, Halcomb WW. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial. Altern Ther Health Med 2006;12(1):34-38
25. Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial. Ear Nose Throat J 2000;79(10):778-80, 782. (Pubitemid 30806574)
26. Hulisz D. Efficacy of zinc against common cold viruses: an overview. J Am Pharm Assoc (2003) 2004;44(5):594-603.
27. Marshall I. Zinc for the common cold. Cochrane Database Syst Rev 2000;(2):CD001364.
28. McElroy BH, Miller SP. An open-label, single-center, phase IV clinical study of the effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) in reducing the duration and symptoms of the common cold in school-aged subjects. Am J Ther 2003;10(5):324-329
29. Mossad SB. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. QJM 2003;96(1):35-43.
30. Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000;133(4):245-252 (Pubitemid 30660296)
31. Silk R, LeFante C. Safety of zinc gluconate glycine (Cold-Eeze) in a geriatric population: a randomized, placebo-controlled, double-blind trial. Am J Ther 2005;12(6):612-617 (Pubitemid 41689763)
32. Turner RB. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin Infect Dis 2001;33(11):1865-1870
33. Turner RB, Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin Infect Dis 2000;31(5):1202-1208
34. Turner RB, Fowler SL, Berg K. Treatment of the common cold with troxerutin. APMIS 2004;112(9):605-611
35. Gruber C, Riesberg A, Mansmann U, Knipschild P, Wahn U, Buhring M. The effect of hydrotherapy on the incidence of common cold episodes in children: a randomised clinical trial. Eur J Pediatr 2003;162(3):168-176 (Pubitemid 36337681)
36. Gorton HC, Jarvis K. The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections. J Manipulative Physiol Ther 1999;22(8):530-533 (Pubitemid 29503503)
37. Niederman R, Kelderman H, Socransky S, Ostroff G, Genco C, Kent R, Jr., Stashenko P. Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice. Arch Oral Biol 2002;47(8):613-618
38. Luhm J, Langenkamp U, Hensel J, Frohn C, Brand JM, Hennig H, Rink L, Koritke P, Wittkopf N, Williams DL, Mueller A. ?-(1?3)-D-glucan modulates DNA binding of nuclear factors ?B, AT and IL-6 leading to an antiinflammatory shift of the IL-1?/IL-1 receptor antagonist ratio. BMC Immunol 2006;7:5.
39. Bedirli A, Kerem M, Pasaoglu H, Akyurek N, Tezcaner T, Elbeg S, Memis L, Sakrak O. Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis. Shock 2007;27(4):397-401. (Pubitemid 46594971)
40. Ikewaki N, Fujii N, Onaka T, Ikewaki S, Inoko H. Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement. Microbiol Immunol 2007;51(9):861-873 (Pubitemid 47450483)
41. Liang J, Melican D, Cafro L, Palace G, Fisette L, Armstrong R, Patchen ML. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharmacol 1998;20(11):595-614. (Pubitemid 28535144)
42. Onderdonk AB, Cisneros RL, Hinkson P, Ostroff G. Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo. Infect Immun 1992;60(4):1642-1647
43. Kaiser AB, Kernodle DS. Synergism between poly-(1-6)-beta-D- glucopyranosyl-(1-3)-beta-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model. Antimicrob Agents Chemother 1998;42(9):2449-2451 (Pubitemid 28420398)
44. Davis JM, Murphy EA, Brown AS, Carmichael MD, Ghaffar A, Mayer EP. Effects of oat beta-glucan on innate immunity and infection after exercise stress. Med Sci Sports Exerc 2004;36(8):1321-1327 (Pubitemid 39014815)
45. Murphy EA, Davis JM, Brown AS, Carmichael MD, Carson JA, Van Rooijen N, Ghaffar A, Mayer EP. Benefits of oat ?-glucan on respiratory infection following exercise stress: role of lung macrophages. Am J Physiol Regul Integr Comp Physiol 2008;294(5):R1593-R1599.
46. Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg 1994;129(11):1204-1210 (Pubitemid 24335973)
47. Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Forse RA. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann Surg 1994;220(5):601-609 (Pubitemid 24985505)
48. Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, Vogel SB, Norman J, Kaufman D, Galandiuk S, Condon RE. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Arch Surg 1999;134(9):977-983 (Pubitemid 29428910)
49. Sandvik A, Wang YY, Morton HC, Aasen AO, Wang JE, Johansen FE. Oral and systemic administration of beta-glucan protects against lipopolysaccharide- induced shock and organ injury in rats. Clin Exp Immunol 2007;148(1):168-177 (Pubitemid 46364988)
50. Kournikakis B, Mandeville R, Brousseau P, Ostroff G. Anthrax-protective effects of yeast beta 1,3 glucans. MedGenMed 2003;5(1):1. (Pubitemid 41348963)
51. Brown GD, Gordon S. Immune recognition of fungal beta-glucans. Cell Microbiol 2005;7(4):471-479
52. Castro GR, Panilaitis B, Bora E, Kaplan DL. Controlled release biopolymers for enhancing the immune response. Mol Pharm 2007;4(1):33-46. (Pubitemid 46302127)
53. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE, Barker LA, Breuel KF, Deponti WK, Kalbfleisch JH, Ensley HE, Brown GD, Gordon S, Williams DL. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 2005;314(3):1079-1086 (Pubitemid 41205971)
54. Nerren JR, Kogut MH. The selective Dectin-1 agonist, curdlan, induces an oxidative burst response in chicken heterophils and peripheral blood mononuclear. Vet Immunol Immunopathol 2009 Jan 15;127(1-2):162-166 Epub 2008 Sep
55. Shah VB, Huang Y, Keshwara R, Ozment-Skelton T, Williams DL, Keshvara L. Beta-glucan activates microglia without inducing cytokine production in Dectin-1-dependent manner. J Immunol 2008 Mar 1;180(5):2777-2785
56. Nieman DC, Henson DA, McMahon M, Wrieden JL, Davis JM, Murphy EA, Gross SJ, McAnulty LS, Dumke CL. ?-Glucan, Immune Function, and Upper Respiratory Tract Infections in Athletes. Med Sci Sports Exerc 2008;40(8):1463-1471